Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMGN

AMGEN Inc.

Dec 07 • 03:54PM ET

271.47

Dollar change +2.12
Percentage change 0.79	%

Healthcare • Drug Manufacturers - General • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	19.30	EPS (ttm)	14.06	Insider Own	0.22%	Shs Outstand	534.00M	Perf Week	0.68%
Market Cap	145.29B	Forward P/E	13.63	EPS next Y	19.91	Insider Trans	-1.81%	Shs Float	533.99M	Perf Month	0.13%
Income	7.57B	PEG	3.70	EPS next Q	4.60	Inst Own	77.20%	Short Float / Ratio	1.27% / 2.75	Perf Quarter	4.64%
Sales	26.63B	P/S	5.46	EPS this Y	4.98%	Inst Trans	-1.49%	Short Interest	6.77M	Perf Half Y	22.97%
Book/sh	14.31	P/B	18.97	EPS next Y	7.21%	ROA	9.81%	Target Price	275.47	Perf Year	-4.17%
Cash/sh	64.91	P/C	4.18	EPS next 5Y	5.21%	ROE	133.80%	52W Range	211.71 - 288.46	Perf YTD	3.36%
Dividend	8.55	P/FCF	15.49	EPS past 5Y	35.08%	ROI	11.34%	52W High	-5.89%	Beta	0.57
Dividend %	3.15%	Quick Ratio	2.56	Sales past 5Y	2.81%	Gross Margin	73.39%	52W Low	28.23%	ATR	4.81
Employees	25200	Current Ratio	2.86	Sales Q/Q	4.36%	Oper. Margin	32.49%	RSI (14)	54.44	Volatility	1.33% 1.68%
Optionable	Yes	Debt/Eq	7.90	EPS Q/Q	-19.27%	Profit Margin	28.41%	Rel Volume	0.57	Prev Close	269.35
Shortable	Yes	LT Debt/Eq	7.71	Earnings	Oct 31 BMO	Payout	64.07%	Avg Volume	2.46M	Price	271.47
Recom	2.39	SMA20	1.33%	SMA50	0.44%	SMA200	9.97%	Volume	1,395,602	Change	0.79%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234
Oct-11-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$257 → $279
May-23-22	Initiated	SVB Leerink	Mkt Perform	$256
Feb-09-22	Reiterated	Wells Fargo	Equal Weight	$210 → $250
Feb-09-22	Reiterated	Oppenheimer	Outperform	$272 → $285
Feb-09-22	Reiterated	Morgan Stanley	Equal-Weight	$235 → $238
Feb-09-22	Reiterated	Jefferies	Buy	$266 → $280
Feb-09-22	Reiterated	Barclays	Equal Weight	$228 → $233
Jan-05-22	Downgrade	BofA Securities	Buy → Neutral	$285 → $255
Dec-09-21	Resumed	Wells Fargo	Equal Weight	$210

Show Previous Ratings

Dec-06-23 06:09PM	Amgen: Relative Valuation Remains Unattractive (GuruFocus.com)
05:50PM	Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Dec-04-23 09:03PM	Dominate the Dow for safe returns, fat dividends with our AI-driven ProPicks (Investing.com)
Dec-03-23 04:14PM	Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer Here Are 2 Stocks to Take Advantage (TipRanks)
Dec-01-23 09:57AM	Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble? (Barrons.com)
08:47AM	Loading…
08:47AM	From Hype to Clinical: Cowen Suggests 2 AI Healthcare Stocks to Consider (TipRanks)
04:30AM	Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives. (Barrons.com)
Nov-30-23 11:30AM	Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-29-23 06:03AM	The Art of Valuation: Discovering Amgen Inc's Intrinsic Value (GuruFocus.com)
Nov-28-23 01:34PM	AWS expands big pharma partnerships on manufacturing, AI, and R&D (Yahoo Finance)
01:34PM	AWS expands big pharma partnerships in manufacturing, AI, and R&D (Yahoo Finance)
10:36AM	This Stock Hasn't Split Since 1999 $1,000 Invested Then Would Be Worth A Boatload Today (Benzinga)
09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
09:00AM	1 Spectacular Dividend Stock Every Investor Should Consider (Motley Fool)
Nov-26-23 03:08PM	5 Best Diabetes Stocks to Buy Now (Insider Monkey)
06:51AM	Loading…
06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
Nov-22-23 04:00PM	AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE (PR Newswire)
Nov-20-23 07:01PM	Billionaire Steven Cohens Top High Dividend Stock Picks (Insider Monkey)
06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
Nov-19-23 05:39AM	18 Best-Performing Dow Stocks in 2023 (Insider Monkey)
Nov-17-23 09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-15-23 09:49AM	1 in 25 carries a genotype that is associated with a shortened lifespan (PR Newswire)
06:02AM	Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc (GuruFocus.com)
05:06AM	Amgen Inc's Dividend Analysis (GuruFocus.com)
Nov-13-23 07:05PM	13 Cheap Blue Chip Stocks To Buy (Insider Monkey)
06:06PM	5 Best Low Beta Stocks To Buy (Insider Monkey)
02:22PM	13 Dividend Giants with Lowest Short Interest (Insider Monkey)
01:06PM	6 intriguing stocks investors should consider: Piper Sandler (Yahoo Finance Video)
Nov-10-23 10:15AM	2 Top Biotech Stocks to Buy Right Now (Motley Fool)
09:00AM	AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023 (PR Newswire)
07:38AM	Loading…
07:38AM	12 Dogs of the Dow Dividend Stocks to Buy (Insider Monkey)
Nov-09-23 08:00AM	US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision (Reuters)
03:49AM	Top 20 Drug Companies in the US by Revenue (Insider Monkey)
Nov-07-23 04:05PM	AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023 (PR Newswire)
04:00PM	AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023 (PR Newswire)
04:00PM	AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJGREN'S SYNDROME AT ACR 2023 (PR Newswire)
Nov-06-23 11:00AM	Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition (PR Newswire)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-02-23 08:00AM	AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA (PEGLOTICASE) (PR Newswire)
01:59AM	Amazon headed for rosy period, says HSBC; Roku flying: 6 big analyst picks (Investing.com)
01:08AM	The Amgen Inc (AMGN) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-01-23 10:31AM	Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
09:00AM	AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO (PR Newswire)
08:30AM	Get Ready for Next Generation of Diabetes, Weight-Management Drugs (PR Newswire)
08:05AM	Company News for Nov 01, 2023 (Zacks)
08:01AM	Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value (GuruFocus.com)
12:12AM	Q3 2023 Amgen Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-31-23 06:58PM	RPT-UPDATE 1-U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug (Reuters)
06:38PM	UPDATE 1-U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug (Reuters)
06:31PM	U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug (Reuters)
06:26PM	REFILE-U.S. FDA approves Amgen's biosimilar version of J&J's Stelara (Reuters)
05:00PM	S&P 500 Gains and Losses Today: Arista Networks Results and Guidance Beat Estimates (Investopedia)
04:06PM	Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug (Investor's Business Daily)
01:18PM	Markets Edge Higher at Midday Ahead of Wednesday's Fed Decision (Investopedia)
12:59PM	Analyst Report: Amgen Inc. (Morningstar Research)
12:56PM	Amgen's obesity drug plans, outlook for 2024 (Yahoo Finance Video)
12:35PM	Never Mind Covid, Investors Want a Pfizer Obesity Pill (The Wall Street Journal)
11:30AM	Amgen (AMGN) Beats on Q3 Earnings Beat, Lags Sales, Ups View (Zacks)
11:13AM	Amgen Boosts Revenue Guidance, but the Stock Is Falling (Barrons.com)
10:32AM	'This field is in its infancy': Amgen noncommittal on oral obesity med until ph. 1 data arrives (FierceBiotech.com)
09:30AM	Here's What Key Metrics Tell Us About Amgen (AMGN) Q3 Earnings (Zacks)
09:05AM	Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel Sales (Investor's Business Daily)
08:49AM	Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings (FierceBiotech.com)
08:32AM	Amgen Inc (AMGN) Q3 2023 Earnings: Revenue Up 4% to $6.9 Billion, GAAP EPS Down 19% to $3.22 (GuruFocus.com)
08:25AM	Amgen (AMGN) Q3 Earnings Top Estimates (Zacks)
07:58AM	UPDATE 1-Amgen third-quarter sales rise 5%; profit up before charge (Reuters)
07:18AM	Amgen: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Amgen sales rise, but shares off as investors await obesity data (Reuters)
07:00AM	AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
Oct-30-23 11:37AM	Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY (Zacks)
05:46AM	11 Best Pharma Stocks To Buy Now (Insider Monkey)
05:25AM	11 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
Oct-29-23 06:30AM	2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now (Motley Fool)
Oct-28-23 11:43AM	Microsoft Leads These 5 Dow Jones Stocks Near Buy Points (Investor's Business Daily)
Oct-27-23 02:52PM	Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen Also Set To Report (Investor's Business Daily)
07:46AM	UPDATE 4-AbbVie takes $2.1 bln charge on cancer drug ahead of US price negotiation (Reuters)
07:39AM	AbbVie raises profit forecast after Humira, newer drugs drive results beat (Reuters)
Oct-26-23 11:00AM	A large international study of migraine reveals new biological pathways for treatment (PR Newswire)
07:30AM	3 Pharma Stocks That Are Screaming Buys in October (Motley Fool)
Oct-25-23 04:00PM	AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
12:09PM	5 Best Dogs of the Dow Stocks Ranked By Hedge Fund Sentiment (Insider Monkey)
10:02AM	UniQure (QURE) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:30AM	Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030 (PR Newswire)
07:26AM	Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates? (Zacks)
04:49AM	USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day (Zacks)
04:28AM	20 Countries with Lowest Rates of Cancer (Insider Monkey)
Oct-24-23 05:50PM	Amgen (AMGN) Outperforms Broader Market: What You Need to Know (Zacks)
04:00PM	AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND (PR Newswire)
03:08PM	Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts (InvestorPlace)
11:02AM	12 Defensive Healthcare Dividend Stocks To Invest In (Insider Monkey)
10:00AM	Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
09:15AM	3 Biotech Stocks With Decent Dividend for a Steady Return (Zacks)
Oct-23-23 06:32AM	The Zacks Analyst Blog Highlights Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk (Zacks)
04:32AM	AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-22-23 10:30AM	AMGEN PRESENTS NEW LUMAKRAS (SOTORASIB) PLUS VECTIBIX (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER (PR Newswire)
Oct-20-23 02:41PM	Top Stock Reports for Apple, Amgen & Becton, Dickinson (Zacks)
10:47AM	Amgen cites 'watershed moment' as tarlatamab offers lifeline for hard-to-reach cancer group (FierceBiotech.com)
09:37AM	SolarEdge downgraded, Crocs upgraded: Wall Street's top analyst calls (The Fly)
08:00AM	AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER (PR Newswire)
Oct-19-23 04:00PM	AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023 (PR Newswire)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Dec 04	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM
AMGEN INC	10% Owner	Sep 19	Buy	17.00	1,764,705	29,999,985	35,368,653	Sep 19 07:52 PM
Gordon Murdo	EVP, Global Commercial Ops	Aug 10	Sale	262.43	9,558	2,508,306	44,308	Aug 11 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience